Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009
Methicillin-resistant Staphylococcus aureus (MRSA) is a human pathogen that has diverse molecular heterogeneity. Most MRSA strains in the United States are pulsed-field gel electrophoresis USA100 sequence type (ST) 5 and USA300 ST8. Infections with MRSA ST239-III are common and found during health c...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2012-10-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/18/10/12-0468_article |
| _version_ | 1818535222814179328 |
|---|---|
| author | Shu-Hua Wang Yosef Khan Lisa Hines José R. Mediavilla Liangfen Zhang Liang Chen Armando Hoet Tammy Bannerman Preeti Pancholi D. Ashley Robinson Barry N. Kreiswirth Kurt B. Stevenson |
| author_facet | Shu-Hua Wang Yosef Khan Lisa Hines José R. Mediavilla Liangfen Zhang Liang Chen Armando Hoet Tammy Bannerman Preeti Pancholi D. Ashley Robinson Barry N. Kreiswirth Kurt B. Stevenson |
| author_sort | Shu-Hua Wang |
| collection | DOAJ |
| description | Methicillin-resistant Staphylococcus aureus (MRSA) is a human pathogen that has diverse molecular heterogeneity. Most MRSA strains in the United States are pulsed-field gel electrophoresis USA100 sequence type (ST) 5 and USA300 ST8. Infections with MRSA ST239-III are common and found during health care–associated outbreaks. However, this strain has been rarely reported in the United States. As part of a study supported by the Prevention Epicenter Program of the Centers for Disease Control and Prevention (Atlanta, GA, USA), which evaluated transmission of MRSA among hospitals in Ohio, molecular typing identified 78 (6%) of 1,286 patients with MRSA ST239-III infections. Ninety-five percent (74/78) of these infections were health care associated, and 65% (51/78) of patients had histories of invasive device use. The crude case-fatality rate was 22% (17/78). Identification of these strains, which belong to a virulent clonal group, emphasizes the need for molecular surveillance. |
| first_indexed | 2024-12-11T18:21:57Z |
| format | Article |
| id | doaj.art-e687c5c80a974dd1be72153a19f487c8 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-12-11T18:21:57Z |
| publishDate | 2012-10-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-e687c5c80a974dd1be72153a19f487c82022-12-22T00:55:13ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592012-10-0118101557156510.3201/eid1810.120468Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009Shu-Hua WangYosef KhanLisa HinesJosé R. MediavillaLiangfen ZhangLiang ChenArmando HoetTammy BannermanPreeti PancholiD. Ashley RobinsonBarry N. KreiswirthKurt B. StevensonMethicillin-resistant Staphylococcus aureus (MRSA) is a human pathogen that has diverse molecular heterogeneity. Most MRSA strains in the United States are pulsed-field gel electrophoresis USA100 sequence type (ST) 5 and USA300 ST8. Infections with MRSA ST239-III are common and found during health care–associated outbreaks. However, this strain has been rarely reported in the United States. As part of a study supported by the Prevention Epicenter Program of the Centers for Disease Control and Prevention (Atlanta, GA, USA), which evaluated transmission of MRSA among hospitals in Ohio, molecular typing identified 78 (6%) of 1,286 patients with MRSA ST239-III infections. Ninety-five percent (74/78) of these infections were health care associated, and 65% (51/78) of patients had histories of invasive device use. The crude case-fatality rate was 22% (17/78). Identification of these strains, which belong to a virulent clonal group, emphasizes the need for molecular surveillance.https://wwwnc.cdc.gov/eid/article/18/10/12-0468_articleStaphylococcus aureusmethicillin-resistant Staphylococcus aureusMRSAMRSA ST239-IIIbacteriasequence type |
| spellingShingle | Shu-Hua Wang Yosef Khan Lisa Hines José R. Mediavilla Liangfen Zhang Liang Chen Armando Hoet Tammy Bannerman Preeti Pancholi D. Ashley Robinson Barry N. Kreiswirth Kurt B. Stevenson Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 Emerging Infectious Diseases Staphylococcus aureus methicillin-resistant Staphylococcus aureus MRSA MRSA ST239-III bacteria sequence type |
| title | Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 |
| title_full | Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 |
| title_fullStr | Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 |
| title_full_unstemmed | Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 |
| title_short | Methicillin-Resistant Staphylococcus aureus Sequence Type 239-III, Ohio, USA, 2007–2009 |
| title_sort | methicillin resistant staphylococcus aureus sequence type 239 iii ohio usa 2007 2009 |
| topic | Staphylococcus aureus methicillin-resistant Staphylococcus aureus MRSA MRSA ST239-III bacteria sequence type |
| url | https://wwwnc.cdc.gov/eid/article/18/10/12-0468_article |
| work_keys_str_mv | AT shuhuawang methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT yosefkhan methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT lisahines methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT josermediavilla methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT liangfenzhang methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT liangchen methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT armandohoet methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT tammybannerman methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT preetipancholi methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT dashleyrobinson methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT barrynkreiswirth methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 AT kurtbstevenson methicillinresistantstaphylococcusaureussequencetype239iiiohiousa20072009 |